1) Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, ShimizuT, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS Study Group. Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry. Rheumatology (Oxford). 2025 Jun 1;64(6):3872-3878. doi:10.1093/rheumatology/keae530. PMID: 39340799.
2) Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Giménez AI, Hinze C, McCann LJ, Reed AM, Rider LG, Arvigo M, Bader-Meunier B, Bruno C, Caifeng L, Campanilho-Marques R, Cuccato S, Fiorillo C, Hahn NA, Huber AM, Jansen M, Kasapcopur O, Katsikas MM, Kim S, Livermore P, Maillard S, Malattia C, Migowa AN, Miyamae T, Murphy R, Nicolai R, Papadopoulou C, Pilkington C, Sanner H, Sawhney S, Smolewska E, Tarvin SE, Tiller G, Toplak N, Wedderburn LR, Bovis F, Consolaro A, Feldman BM. Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force. Ann Rheum Dis. 2025 Jul;84(7):1055-1067. doi: 10.1016/j.ard.2025.04.024. Epub 2025 May 22. PMID: 40410052; PMCID: PMC12229752.
3) Miyamae T*, Manabe Y, Sugihara T, Umezawa N, Yoshifuji H, Tamura N, Abe Y, Furuta S, Nagafuchi H, Ishizaki J, Nakano N, Atsumi T, Karino K, Amano K, Kurasawa T, Ito S, Yoshimi R, Ogawa N, Banno S, Naniwa T, Ito S, Hara A, Hirahara S, Uchida HA, Onishi Y, Murakawa Y, Komagata Y, Nakaoka Y, Harigai M. Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective study. Mod Rheumatol. 2025 Feb 21;35(2):339-344. doi:10.1093/mr/ roae068. PMID: 39116014.
4) Shimizu M, Inoue E, Sakai R, Inoue Y, Mitsunaga K, Sugihara T, Hirano T,Izawa K, Kishida D, Matsushita M, Mori M, Narazaki H, Nishikomori R, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H, Miyamae T. Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan. Mod Rheumatol. 2025 Sep 2;35(5):909-915. doi: 10.1093/mr/ roaf032. PMID:40160024.
5) Miyamae T*, Okamoto N, Inoue Y, Kubota T, Ebato T, Irabu H, Kameda H, Kaneko Y, Kubo H, Mitsunaga K, Mori M, Nakajima A, Nishimura K, Ohkubo N, Sato T, Sugita Y, Takanashi S, Tanaka T, Umebayashi H, Yashiro M, Yamanishi S, Fusama M, Hirata S, Kishimoto M, Kohno M, Kojima M, Kojima T, Morinobu A, Sugihara T, Tanaka E, Yajima N, Yanai R, Kawahito Y, Harigai M. Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis – secondary publication. Mod Rheumatol. 2025 Sep 2;35(5):894-908. doi: 10.1093/mr/roaf042.PMID: 40459241.
6) Hamaguchi Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, Miyamae T, Ishikawa H, Ae R, Nakamura Y, Asano Y, Fujimoto M; Ministry of Health, Labour and Welfare's Localized Scleroderma Research Group. Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan. J Dermatol. 2025 May;52(5):860-871.doi: 10.1111/1346-8138.17684. Epub 2025 Mar 5. PMID: 40040588.
7) Inoue Y, Sakai R, Inoue E, Mitsunaga K, Shimizu M, Sugihara T, Matsushita M, Yamaji K, Mori M, Shimojo N, Miyamae T. Nationwide epidemiological survey of juvenile idiopathic arthritis during transition to young adulthood in Japan using the National Database of Designated Incurable Diseases of Japan. Mod Rheumatol. 2025 Feb 21;35(2):359-365. doi: 10.1093/mr/roae076. PMID: 39172631.
8) Fusama M, Nakahara H, Urata Y, Kawahata K, Kawahito Y, Kojima M, Sugihara T, Hashimoto M, Miyamae T, Murashima A, Mori M, Yajima N, Matsui T. Challenges nurses face in providing care to older patients with rheumatoid arthritis: A qualitative study. Mod Rheumatol. 2025 Feb 21;35(2):256-264. doi:10.1093/mr/roae087. PMID: 39233450.
9) Inoue Y, Sakai R, Inoue E, Mitsunaga K, Yamaji K, Mori M, Tomiita M, Shimojo N, Miyamae T. Nationwide epidemiological survey of primary Sjogren's disease in Japan using the National Database of Designated Intractable Diseases. Mod Rheumatol. 2025 Sep 2;35(5):859-865. doi: 10.1093/mr/roaf027. PMID: 40085073.
10) Matsushita M, Sakai R, Yokogawa N, Shimizu M, Inoue Y, Inoue E, Yamaji K, Mori M, Miyamae T. Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: A cross-sectional study based on the National Database of Health Insurance Claims. Mod Rheumatol. 2025 Sep 2;35(5):850-858. doi: 10.1093/mr/roaf020. PMID: 40066996.
11) Miyamae T*, Sakai R, Inoue Y, Kato D, Inoue E, Hirano T, Izawa K, Kishida D, Matsushita M, Mitsunaga K, Mori M, Narazaki H, Nishikomori R, Shimizu M, Sugihara T, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H, Tanaka E, Harigai M. Comparative Clinical Practice of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Adolescents and Young Adults: A Retrospective Cohort Study Using Japanese Health Insurance Claims Data (2016-2020). Mod Rheumatol. 2025 Apr 7:roaf035. doi: 10.1093/mr/roaf035. Epub ahead of print. PMID: 40193103.
12) Sumitomo S, Hirano T, Moriichi A, Inoue Y, Narazaki H, Inoue M, Yokogawa N, Kambe N, Mukai T, Izawa K, Kishida D, Yoshifuji H, Yamaji K, Nishikomori R, Mori M, Miyamae T. Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases. Mod Rheumatol. 2025 Jul 5;35(4):599- 611. doi:10.1093/mr/roaf036. PMID: 40186369.
13) Sada KE, Iwata S, Inoue Y, Tanaka E, Nishida K, Kawahito Y, Abe A, Kawakami A, Miyamae T. Telemedicine as an alternative to in-person care in the field of rheumatic diseases: A systematic scoping review. Mod Rheumatol. 2025 Jul 5;35(4):715-721. doi: 10.1093/mr/roaf012. PMID: 39943803.
14) Inoue Y, Kishi T, Sato T, Yamazaki K, Iwata S, Abe A, Sada KE, Tanaka E, Nishida K, Kawakami A, Kawahito Y, Miyamae T. Telemedicine for Paediatric Rheumatic Diseases in Japan: A National Survey of Physicians' Perspectives. Mod Rheumatol. 2025 Aug 6:roaf075. doi: 10.1093/mr/ roaf075. Epub ahead of print. PMID: 40794858.
15) Iwata S, Nishida K, Inoue Y, Abe A, Sada K, Tanaka E, Kawakami A, Kawahito Y, Miyamae T. The need for telemedicine for rheumatic diseases in adult medical care:A Survey of non-pediatric rheumatologists. Mod Rheumatol. 2025 Jul 20:roaf068. doi: 10.1093/mr/roaf068. Epub ahead of print. PMID: 40684796.
16) Kato D, Miyamae T, Inoue Y. Medical treatment recipient ratio for metal allergy among Japanese children and adolescents: A retrospective cohort study using health insurance claims data (2016-2020). Allergol Int. 2025 Jul;74(3):491-493. doi: 10.1016/j.alit.2025.04.001. Epub 2025 Apr 17. PMID:40246639.
17) Yokogawa N, Sakai R, Matsushita M, Shimizu M, Inoue Y, Inoue E, Yamaji K, Mori M, Miyamae T. Delayed global standardization and prefectural disparities in systemic lupus erythematosus treatment in Japan: A nationwide study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Mod Rheumatol. 2025 Feb 21;35(2):294-299. doi: 10.1093/mr/roae072. PMID:39167459.
18) Nakamura S, Okamoto Y, Takada H, Katsumata Y, Harigai M. A shared monocyte cytokine signature induced by serum from patients with systemic lupuserythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathway. Immunol Lett. 2025 Dec;276:107066. doi:10.1016/j.imlet.2025.107066. Epub 2025 Aug 6. PMID: 40780484.
19) Yamashita S, Katsumata Y, Baba S, Okamoto Y, Konda N, Harigai M. Validity and reliability of the Japanese version of LupusQoL: Assessment of disease-specific health-related quality of life in systemic lupus erythematosus. Lupus. 2025 Jul;34(8):810-818. doi: 10.1177/09612033251344995. Epub 2025 May 19. PMID: 40387115.
20) Ito M, Okamoto T, Shimamura T, Adachi T, Okamoto Y, Saito H, Tsutsui T, Yoshii S, Yamashita S, Kobayashi M, Inoue Y, Chiaki T, Miyashita Y, Oba T, Saito K, Miyazaki Y. Rheumatoid arthritis development and survival in idiopathic interstitial pneumonia patients with anti-citrullinated protein antibodies. Respir Investig. 2025 Jul;63(4):554-559. doi: 10.1016/j.resinv.2025.04.014. Epub 2025 Apr 29. PubMed PMID: 40300410.
21) Irabu H, Ohara A, Nakamura A, Narazaki H, Hayashi Y, Yamasaki Y, Iwata N, Ohshima S, Nishiyama S, Nakagishi Y, Fukuhara D, Ishida H, Goto M, Hashimoto K, Yasuoka R, Nozawa T, Miyamae T, Umebayashi H, Mori M, *Shimizu M. Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus. Mod Rheumatol. 2025 Oct 8: roaf088. doi: 10.1093/mr/roaf088. Epub ahead of print. PMID: 41060294.
22) *Kaneko U, Miyamae T, Hamaguchi Y, Shimizu M, Ueda-Hayakawa I, Ishikawa H, Ae R, Nakamura Y, Asano Y, Kawaguchi Y, Kuwana M, Goto D, Hasegawa M, Hatano M, Isomura Y, Jinnin M, Kanatani Y, Kumanogoh A, Makino T, Makino K, Matsushita T, Motegi SI, Mugii N, Okiyama N, Shima Y, Takahashi H, Tanaka S, Yamamoto T, Yasuoka H, Maki H, Yoshizaki A, Fujimoto M; Ministry of Health, Labour and Welfare's Systemic Sclerosis Research Group. Clinical and Epidemiological Features of Juvenile-Onset Systemic Sclerosis From a Nationwide Survey in Japan. J Rheumatol. 2026 Feb 1: jrheum.2025-0175. doi: 10.3899/jrheum.2025-0175. Epubahead of print. PMID: 40953948.
23) Kawashiri SY, Kawakami A, Miyamae T. A proposal for the implementation of telemedicine in Japan for rheumatoid arthritis, juvenile idiopathic arthritis, and systemic lupus erythematosus: review article. Mod Rheumatol. 2026 Mar 23:roag023. doi: 10.1093/mr/roag023. Online ahead of print.PMID: 41870492.
24) Nakaoka Y, Watanabe Y, Sugihara T, Nagasaka K, Tamura N, Yoshifuji H, Yajima N, Aono F, Hashimoto T, Ishizu A, Iida T, Ishii T, Kiko T, Maejima Y, Miyamae T, Nakano Y, Nanki T, Niiro H, Ota H, Okochi N, Sada K, Shigematsu K, Uchida HA, Abe Y, Aoki-Kamiya C, Arita Y, Handa T, Hiwa R, Honda M, Ishihara R, Ishizaki J, Ito S, Iwahashi T, Iwata N, Kadoba K, Kamiyama Y, Kawazoe M, Kida T, Kidoguchi G, Kobayashi D, Kobayashi K, Kurata A, Miyawaki Y, Nakagama S, Nishioka N, Onimaru M, Onishi Y, Sakai R, Sakai R, Sanada H, Shimizu Y, Shirai T, Sugano E, Takahashi K, Tamechika SY, Ueda J, Umezawa N, Watanabe R, Yanai R, Yoshida T, Amano K, Harigai M, Isobe M, Kitaoka H, Tanemoto K; Japanese Circulation Society Joint Working Group. JCS 2026 Guideline on Management of Large Vessel Vasculitis. Circ J. 2026 Mar 20. doi: 10.1253/circj.CJ-25-0969. Online ahead of print.PMID: 41866178 .